A recent study conducted in Colorado has shed light on the accuracy of labels on cannabis products sold at dispensaries in the state. The study, published in the journal Scientific Reports, revealed that nearly half of cannabis flower products are inaccurately labeled when it comes to potency, with most products showing higher THC content than what is actually contained in them. In contrast, labels on cannabis concentrates such as oils and waxes were found to be more accurate, with 96% of products matching the labeled potency.
The research, conducted in collaboration with MedPharm Research, LLC, a licensed cannabis testing facility, manufacturer, and retailer, aimed to evaluate the labeling accuracy of cannabis products in the legal market. A total of 277 products from 52 dispensaries across 19 counties were analyzed, including 178 flower products and 99 smokable concentrates. The study focused on THC content, the main psychoactive ingredient in cannabis, which has seen a significant increase in potency over the years.
Results showed that, on average, flower products contained about 21% THC, while concentrates had an average THC content of 71%, with some products reaching as high as 84%. The study highlighted that accurate labeling of cannabis products is crucial for both medical and recreational users, as incorrect potency information can lead to improper dosing and potential risks.
While concentrates were found to have accurate labels in the study, discrepancies in flower products were more prevalent, with 44% of products failing to meet the 15% threshold for labeling accuracy. The researchers emphasized the importance of providing consumers with accurate information about the THC content in cannabis products to ensure safe and responsible use.
In addition to THC, the study also looked at other cannabinoids present in the products, such as CBD, CBG, and CBGA. While Colorado law requires CBD levels to be listed on labels, information about other cannabinoids was found to be lacking in most products. The researchers stressed the need to include a broader range of cannabinoid information on labels to better inform consumers about the product they are purchasing.
Moving forward, the researchers plan to expand their study to include cannabis edibles and further investigate labeling practices in the industry. As more states legalize cannabis for medicinal and recreational use, research like this can help inform regulations and ensure the safety and integrity of the cannabis industry.
Overall, the study highlights the importance of accurate labeling in the cannabis market and the need for continued monitoring and improvement to provide consumers with reliable information about the products they are using.
